Search the Newsreel

SEB Asset Management AB Makes New $2.85 Million Investment in IDEX Corporation $IEX

SEB Asset Management AB initiated a new position in IDEX Corporation (NYSE:IEX) during the first quarter, acquiring 15,062 shares valued at approximately $2.85 million. This comes after IDEX reported strong quarterly results, exceeding EPS and revenue estimates, and subsequently raising its guidance for Q2 …

IDEX stock trades steady as recent earnings underscore cash generation

IDEX Corporation's stock shows steady performance driven by solid revenue growth, strong margins, and consistent cash generation, as highlighted in its recent financial reports. For fiscal 2025, the company reported revenues near $2.9 billion and net income of about $530 million, with a 7.7% …

Clarkston Capital Partners LLC Reduces Stock Position in IDEX Corporation $IEX

Clarkston Capital Partners LLC significantly reduced its stake in IDEX Corporation, selling 63.7% of its holdings, bringing their total ownership to 36,260 shares valued at $6.87 million. Despite this, other institutional investors increased their positions in IDEX. The article also details IDEX's recent financial …

First Trust Advisors LP Cuts Stock Holdings in IDEX Corporation $IEX

First Trust Advisors LP significantly reduced its stake in IDEX Corporation, selling 23.3% of its shares in the first quarter. Despite this, other institutional investors have either bought new positions or increased their holdings in IDEX. The company's CEO also sold a substantial number …

Earnings Preview: IDEX Corp to Report Financial Results Pre-market on July 29

IDEX Corp (NYSE: IEX) is scheduled to announce its financial results pre-market on July 29. Analysts expect the company to report earnings of $1.76 per share on revenue of $821.57 million for the upcoming quarter. The company has a history of outperforming earnings expectations, …

IRIDEX Corp (IRIX) Valuation: PE, PB & Fair Value Analysis

The article provides a valuation analysis for IRIDEX Corp (IRIX), stating its current valuation score is 9.12, ranking 36th in the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio of -4.81, indicating it is significantly below its recent high and above …

IRIDEX Corp (IRIX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of IRIDEX Corp (IRIX), detailing its current price momentum score, support and resistance levels, and insights from various technical indicators and moving averages. As of July 23, 2026, IRIX trades between resistance at 1.12 and support at 0.81, …

IDEXX stock trades near record territory as recurring diagnostics revenue supports double digit grow

IDEXX Laboratories Inc. (IDXX) continues to show strong double-digit growth, driven by recurring diagnostics revenue and high test volumes, according to its Q1 2026 report. The company's Companion Animal Group (CAG) remains its core engine, with operating leverage supporting increased profitability as its installed …

Walleye Capital LLC Makes New $4.06 Million Investment in IDEX Corporation $IEX

Walleye Capital LLC invested $4.06 million in IDEX Corporation, acquiring 21,426 shares in the first quarter of 2026. This investment comes as several analysts have raised their price targets for IDEX, contributing to a "Moderate Buy" consensus rating. IDEX reported strong quarterly results, exceeding …

IDXX: Idexx Laboratories Inc Latest Stock Price, Analysis, News and Trading Ideas

This article provides current stock information for Idexx Laboratories Inc (IDXX), including its latest stock price, market capitalization, P/E ratio, and upcoming earnings date. It also lists recent news articles related to medical devices and general market trends, alongside popular community discussions about other …

IDEX Corporation (NYSE:IEX) Given Average Rating of "Moderate Buy" by Analysts

IDEX Corporation (NYSE:IEX) has received a "Moderate Buy" consensus rating from analysts, with six firms issuing buy recommendations and three recommending hold. The average one-year price target for the stock is $244.00. Recent analyst actions include target price adjustments and new coverage, while insider …

IDEXX (IDXX) Stock Looks Undervalued On Cash Flow While Earnings Look Overvalued

IDEX closes near its yearly peak as Specialty Machinery peers fall 3.4%

IDEX finished the week 2.9% below its 52-week high, with an active Trend Signal and positive pressure readings offset by ordinary volume and an undecided expectancy score.

IDEX (IEX) Gets a Buy from Oppenheimer

Oppenheimer analyst Bryan Blair has maintained a Buy rating on IDEX (IEX) with a price target of $260.00. This recommendation aligns with a Strong Buy consensus among analysts, with an average price target of $248.70 for IDEX. Despite positive financial results for the quarter …

IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors

IDEXX Laboratories Inc. (IDXX) stock fell 1.35% on Wednesday, closing at $545.00, marking its fourth consecutive day of losses. This underperformance occurred on a generally poor trading day where the S&P 500 Index and Dow Jones Industrial Average also saw declines.

Idex (IEX) Earnings Expected to Grow: Should You Buy?

The market expects Idex (IEX) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended June 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence …

Bank of New York Mellon Corp Decreases Stock Holdings in IDEX Corporation $IEX

Bank of New York Mellon Corp has reduced its stock holdings in IDEX Corporation by 16.7% in the first quarter, selling over 81,000 shares. Despite this, other hedge funds significantly increased their positions in IDEX, and the company recently announced a quarterly dividend of …

IDEX Corporation $IEX Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System reduced its stake in IDEX Corporation by 6.7% in the first quarter, selling 11,067 shares and now owning 154,528 shares valued at $29.29 million. Other institutional investors have adjusted their holdings, and company CEO Eric D. Ashleman also sold …

IDEX stock holds firm as recent earnings highlight resilient margins and cash generation

IDEX Corporation's stock (IDEX) demonstrates steady fundamentals, with recent earnings showcasing solid revenue growth, resilient margins, and strong cash generation across its diverse industrial businesses. The company's focus on niche engineered products and disciplined capital allocation, including dividends and selective acquisitions, supports its appeal …

IEX Maintained by Oppenheimer -- Price Target Raised to $260

Oppenheimer analyst Bryan Blair maintained an Outperform rating on IDEX (IEX) and raised its price target to $260 from $250. This decision reflects growing confidence in the company's operational performance, with IEX currently valued as slightly undervalued according to GuruFocus's GF Value™ and boasting …

Oppenheimer Adjusts Price Target on IDEX to $260 From $250, Maintains Outperform Rating

Oppenheimer has increased its price target for IDEX (IEX) to $260 from $250, while reiterating an "Outperform" rating on the stock. This adjustment reflects a continued positive outlook from the firm regarding IDEX's financial prospects and market position. The article, primarily a news brief, …

IDEXX Laboratories stock trades near record range as recurring veterinary revenue supports margins

IDEXX Laboratories' stock is performing strongly due to expanding recurring revenue from veterinary diagnostics and software. The company reported double-digit growth in its most recent quarter, driven by companion animal diagnostics and practice management solutions, leading to robust profitability and margin expansion. This solid …

Hsbc Holdings PLC Boosts Position in IDEX Corporation $IEX

Hsbc Holdings PLC significantly increased its stake in IDEX Corporation, buying an additional 62,972 shares to own 297,161 shares, valued at $56.2 million. Several other hedge funds also adjusted their positions in IDEX, with notable increases from Primecap Management Co. CA and Dodge & …

Fifth Third Bancorp Buys 12,680 Shares of IDEX Corporation $IEX

Fifth Third Bancorp significantly increased its stake in IDEX Corporation by 400.1% in the first quarter, now owning 15,849 shares valued at $3.004 million. Other institutions also adjusted their holdings, and insider activity shows CEO Eric D. Ashleman sold a substantial number of shares …

IDEX stock trades steadily as fluid and metering businesses support earnings

IDEX Corporation's stock (US45167R1041) is trading steadily, supported by consistent revenue growth, solid margins, and strong cash generation from its fluid and metering technologies. The company maintains a diversified product portfolio across industrial, municipal, and healthcare sectors, enabling mid-single-digit to low-double-digit organic expansion. Its …

IDEX Corp. stock underperforms Monday when compared to competitors

Shares of IDEX Corp. (IEX) fell 1.64% on Monday, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also saw declines. This marked the second consecutive day of losses for the stock.

Stifel Adjusts Price Target on IDEX to $257 From $250, Maintains Buy Rating

Stifel has increased its price target for IDEX (IEX) to $257 from $250, while reiterating a Buy rating on the stock. This adjustment reflects an updated valuation by the firm.

Iridex expands EyeProGPO offering with EndoProbe handpieces

Iridex Corporation has expanded its EyeProGPO product offering to include its EndoProbe Handpieces, providing over 4,300 EyeProGPO members with access to preferred pricing. This move broadens access to their retina laser systems and delivery devices for ophthalmology practices, surgery centers, and hospitals. Despite trading …

More Than 4,300 EyeProGPO Members Gain Preferred EndoProbe Pricing

Iridex (NASDAQ: IRIX) has expanded its partnership with EyeProGPO, an ophthalmology group purchasing organization, to include its EndoProbe Handpieces. This addition provides more than 4,300 EyeProGPO members with access to preferred pricing on these single-use vitreoretinal laser delivery devices. The expanded offering aims to …

Meeder Asset Management Inc. Invests $2.60 Million in IDEX Corporation $IEX

Meeder Asset Management Inc. recently acquired 13,704 shares of IDEX Corporation, valued at approximately $2.6 million, during the first quarter. This investment comes as IDEX reported strong quarterly results, with EPS of $2.00 and revenue up 8.9% year-over-year. The company maintains a "Moderate Buy" …

IDEXX Laboratories stock stays anchored to its diagnostics growth

IDEXX Laboratories' stock performance remains tied to strong demand for its veterinary diagnostics, instruments, and software. The company reported significant financial growth in fiscal 2025, with revenues reaching $3.97 billion and net income at $1.08 billion, alongside improved diluted EPS of $13.01. This consistent …

16,108 Shares in IDEX Corporation $IEX Bought by Heartland Advisors Inc.

Heartland Advisors Inc. recently acquired 16,108 shares of IDEX Corporation (NYSE:IEX) in the first quarter, valued at approximately $3.053 million, according to its SEC filing. Other institutional investors also adjusted their holdings in the industrial products company. IDEX reported strong first-quarter earnings, beating analyst …

IDEX stock trades steady as margins and cash flow support valuation

IDEX Corporation's stock remains stable, supported by strong margins, robust cash flow, and strategic investments in fluid and metering technologies. The company exhibits consistent profitability through disciplined capital allocation, niche industrial demand, and effective cost management, leading to sustained earnings and free cash flow …

IDEX stock trades steady as investors weigh recent earnings and margin trends

IDEX Corporation's stock performance reflects a balance between stable demand for its industrial flow technologies and evolving margin dynamics. The company reported continued top-line expansion, strong cash generation, and attractive operating margins, supporting its position as a consistent performer. Investors are focused on its …

Regents Gate Capital LLP Has $24.71 Million Stock Position in IDEX Corporation $IEX

Regents Gate Capital LLP significantly increased its stake in IDEX Corporation (NYSE:IEX) by 59.9% in the first quarter, now holding 130,389 shares valued at $24.7 million. This move follows IDEX's strong quarterly financial performance, exceeding EPS and revenue expectations, and providing optimistic guidance for …

Financiere des Professionnels Fonds d investissement inc. Purchases Shares of 11,100 IDEX Corporation $IEX

Financiere des Professionnels Fonds d investissement inc. initiated a new position in IDEX Corporation by purchasing 11,100 shares valued at approximately $2.1 million during the first quarter. Several analysts have upgraded their ratings and raised price targets for IDEX, contributing to a "Moderate Buy" …